Cannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use.
about
Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis.Involvement of medial prefrontal cortex alpha-2 adrenoceptors on memory acquisition deficit induced by arachidonylcyclopropylamide, a cannabinoid CB1 receptor agonist, in rats; possible involvement of Ca2+ channels.
P2860
Cannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cannabinoids for the treatment ...... eutic effects of cannabis use.
@en
type
label
Cannabinoids for the treatment ...... eutic effects of cannabis use.
@en
prefLabel
Cannabinoids for the treatment ...... eutic effects of cannabis use.
@en
P2093
P2860
P356
P1476
Cannabinoids for the treatment ...... eutic effects of cannabis use.
@en
P2093
Antony F Henderson
Carissa M Coulston
Gin S Malhi
Michael Perdices
P2860
P304
P356
10.1155/2011/501726
P577
2010-07-27T00:00:00Z